Rearrangement of Allylic Sulfoximines
J . Org. Chem., Vol. 61, No. 16, 1996 5521
7.24 (2H, d, J ) 8 Hz), 5.45 (1H, t, J ) 6 Hz), 4.32 (1H, d, J )
13.6 Hz), 4.03 (1H, d, J ) 13.6 Hz), 2.38 (3H, s), 2.21-2.08
(2H, m), 1.93 (2H, broad), 1.70-1.56 (2H, m), 1.42-1.26 (4H,
m). 13C NMR: δ 142.6, 141.0, 140.9, 135.7, 134.1, 130.7, 129.1,
129.0, 128.8, 126.6, 68.9, 33.4, 31.7, 28.8, 26.04, 26.02, 21.5.
MS (ES + ve): m/ z 404 (M + H+, 15), 296 (100), 233 (50).
Gen er a l Meth od of Meth yla tion of Allylic Su lfox-
im in es 11, 13a , a n d 13b. To a solution of the allylic
sulfoximine (11, 13a , or 13b) (1 mmol) in dry THF (3 mL) was
added LDA (1.3 equiv) at -78 °C, and the reaction mixture
was stirred for 40 min. The orange red solution was treated
with CH3I (2 equiv) at -78 °C, and the reaction was stirred
for a further 1 h at -78 °C and was quenched by the addition
of a saturation aqueous solution of NH4Cl (0.5 mL) at -78 °C.
The reaction was warmed to rt, poured into water (10 mL),
and extracted with CH2Cl2 (2 × 20 mL). The extracts were
concentrated and dried under vacuum to leave a light yellow
oil that decomposed upon attempted purification by column
chromatography on silica gel.
N-Tosyl-N-(1-cyclop en t-1-en yl)m eth yla m in e (12). 1H
NMR (300 MHz): δ 7.75 (2H, dt, J ) 8.4, 1.8 Hz), 7.30 (2H,
dd, J ) 8.4, 0.9 Hz), 5.49 (1H, s), 4.84 (1H, br), 3.60 (2H, d, J
) 4.8 Hz), 2.43 (3H, s), 2.25-2.12 (4H, m), 1.84-1.74 (2H, m).
13C NMR (75 MHz): δ 143.2, 139.3, 137.1, 129.5, 127.5, 127.1,
43.7, 33.1, 32.2, 23.2, 21.4. MS (ES + ve): m/ z 252 (M + H+,
25), 106 (50), 104 (100), 81 (95). HRMS calcd for C13H17NO2S
) 251.09798; found 251.097812.
N-Tosyl-N-(1-cycloh ex-1-en yl)m eth yla m in e (14a ). 1H
NMR: δ 7.43 (2H, d, J ) 8 Hz), 7.30 (2H, d, J ) 8 Hz), 5.34
(1H, s), 4.59 (1H, broad), 3.43 (2H, d, J ) 6.4 Hz), 2.43 (3H,
s), 1.91 (2H, br), 1.85 (2H, br), 1.54-1.45 (4H, m). 13C NMR
(75 MHz): δ 143.2, 137.3, 132.9, 129.5, 127.1, 125.3, 49.6, 26.2,
24.9, 22.3, 22.0, 21.4. MS (ES + ve): m/ z 266 (M + H+, 10),
110 (100). HRMS calcd for C14H19NO2S ) 265.11362; found
265.11318.
N-(Met h oxyca r b on yl)-N-(1-cycloh ex-1-en yl)m et h yl-
a m in e (14b). 1H NMR: δ 5.57 (1H, s), 4.67 (1H, broad), 3.68
(5H, broad, CH2 and CH3), 2.03-1.97 (2H, br), 1.96-1.90 (2H,
br), 1.68-1.52 (4H, m). 13C NMR: δ 157.1, 134.6, 122.8, 52.1,
47.1, 26.3, 24.9, 22.5, 22.3. MS (ES + ve): m/ z 170 (M + H+,
100), 106 (50), 104 (100), 88 (95). HRMS calcd for C9H15NO2
) 169.11026; found 169.110059.
N-Tosyl-S-p h en yl-S-(1-cyclop en t -1-en ylet h yl)su lfox-
im in e (17). 1H NMR (in part): δ 7.84-7.19 (9H, m), 5.46 (1H,
br), 4.31 (1H, q, J ) 7.2 Hz), 2.36 (3H, s), 1.53 (3H, d, J ) 7.2
Hz).
N -Tosyl-S-p h e n yl-S-(1-cycloh e x-1-e n yle t h yl)su lfox-
im in e (19a ). 1H NMR: δ 7.89-7.86 (2H, m), 7.83-7.81 (2H,
m), 7.67-7.63 (1H, m), 7.57-7.53 (2H, m), 7.23-7.21 (2H, m),
5.40 (1H, br), 3.88 (1H, q, J ) 7.4 Hz), 2.38 (3H, s), 1.98-1.83
(2H, m), 1.74-1.69 (2H, m), 1.55 (3H, d, J ) 7.4 Hz), 1.46-
1.32 (4H, m). 13C NMR δ 142.4, 141.2, 135.7, 134.2, 133.9,
129.4, 129.1, 129.0, 128.9, 126.6, 70.2, 26.3, 25.6, 22.4, 21.5,
21.4, 11.8.
N-(Met h oxyca r b on yl)-S-p h en yl-S-(1-cycloh ex-1-en yl-
eth yl)su lfoxim in e (19b). 1H NMR (300 MHz): δ 7.84-7.81
(2H, m), 7.64-7.61 (1H, m), 7.57-7.55 (2H, m), 5.39 (1H, br),
3.92 (1H, q, J ) 7.2 Hz), 2.62 (3H, s), 2.25-1.32 (8H, m), 1.66
(3H, d, J ) 7.2 Hz). 13C NMR (75 MHz): δ 159.5, 133.5, 132.2,
129.9, 129.0, 128.9, 124.7, 65.8, 53.0, 26.4, 25.5, 22.4, 21.5, 12.1.
HRMS calcd for C16H21NO3S ) 307.12419; found 307.126527.
Gen er a l Meth od of P a lla d iu m (0)-Ca ta lyzed Allylic
Su lfoxim in e to Allylic Su lfon a m id e Rea r r a n gem en t. To
a stirred solution of the pure allylic sulfoximine (7, 9, 11, 13a ,
13b, 13c, or 15) or the crude allylic sulfoximine (17, 19a , or
19b) (1 mmol) in dry THF (20 mL) was added freshly prepared
tetrakis(triphenylphosphine)palladium(0) (58 mg, 5 mol %)
under N2 at rt. After TLC analysis indicated complete
consumption of the starting allylic sulfoximine, the reaction
was diluted with ether (20 mL) and then washed with water
(20 mL). The orange solution was concentrated to leave a thick
dark red oil. The oil was dissolved in a 1:10 mixture of 10%
aqueous NaOH (2 mL) and MeOH (20 mL) at room tempera-
ture, and the reaction mixture was stirred for 2 h. The MeOH
was then removed. Water (10 mL) was added, and the mixture
was neutralized by the addition of a 5% aqueous solution of
HCl to pH 7. The mixture was extracted with CH2Cl2 (2 × 20
mL), and the combined extracts were dried (MgSO4) and
concentrated to leave a dark red oil which was purified with
column chromatography. Elution with ethyl acetate/hexane
gave the allylic sulfonamide.
(E)-N-Tosyl-N-[1-(3-p h en yl-2-p r op en yl)]a m in e (8). 1H
NMR: δ 7.78 (2H, d, J ) 8 Hz), 7.33-7.24 (7H, m), 6.45 (1H,
d, J ) 16 Hz), 6.02 (1H, dt, J ) 16, 6.4 Hz), 4.46 (1H, br), 3.76
(2H, dt, J ) 6.4, 1.2 Hz), 2.43 (3H, s). 13C NMR: δ 143.6, 137.0,
136.0, 133.2, 129.8, 128.6, 128.0, 127.2, 126.4, 124.0, 45.5, 21.5.
MS (ES + ve): m/ z 288 (M + H+, 25), 149 (30), 117 (100), 115
(85), 91 (40). HRMS calcd for C16H17NO2S ) 287.09798; found
287.09776.
N-Meth yl-N-(1-cycloh ex-1-en yl)m eth ylam in e (14c). The
title compound was prepared from 13c (200 mg, 0.8 mmol)
according to the general method described above except that
the crude rearrangement products were dissolved in MeOH
(4 mL) and treated with trifluoroacetic acid (0.12 mL, 1.6
mmol) at 0 °C. The reaction mixture was stirred for 2 h at 0
°C, and the solvent was then removed in vacuo at 35 °C. The
residue was dissolved in ether (10 mL) and extracted with a
15% aqueous solution of HCl (2 × 5 mL). The aqueous layers
were combined and cooled to 5 °C. CH2Cl2 (10 mL) was added,
and the resulting biphasic mixture was carefully neutralized
to pH 9 with solid NaHCO3. The organic layer was separated,
and the aqueous phase was extracted with CH2Cl2 (2 × 10 mL).
The combined organic extracts were washed with water (20
mL) and brine (20 mL) then dried (MgSO4) and concentrated
to give a colorless oil. The title compound was then converted
to its less volatile N-tosyl derivative for characterization using
the following procedure. The oil was dissolved in pyridine (2
mL) and tosyl chloride (152 mg, 0.8 mmol) was added in one
portion at 0 °C. After 10 min, the reaction was warmed to rt
and was then stirred overnight. Water (10 mL) was added,
and the mixture was extracted with CH2Cl2 (2 × 10 mL). The
combined extracts were washed with a 10% aqueous solution
of HCl (10 mL) and then water (20 mL). The extract was dried
(MgSO4) and concentrated to give the crude product which was
purified by column chromatography. Elution with 10% ethyl
acetate/hexane gave 47 mg (21% overall yield) of N-methyl-
N-tosyl-N-(1-cyclohex-1-enyl)methylamine and N-methylphe-
nylsulfinamide (68%) (1H NMR (300 MHz) δ 7.72-7.69 (2H,
m), 7.52-7.50 (3H, m), 4.18 (1H, br), 2.55 (3H, d, J ) 3.9 Hz);
MS (EI + ve) m/ z 156 (M + H+, 30), 64 (100)).
N-Met h yl-N-t osyl-N-(1-cycloh ex-1-en yl)m et h yla m in e
Der iva tive of 14c. 1H NMR (300 MHz): δ 7.66 (2H, d, J )
8.4 Hz), 7.32 (2H, d, J ) 8.4 Hz), 5.55 (1H, s), 3.42 (2H, s),
2.57 (3H, s), 2.43 (3H, s), 2.03-1.95 (4H, br), 1.68-1.52 (4H,
br). 13C NMR (75 MHz): δ 143.1, 132.7, 129.6, 127.6, 127.5,
126.6, 56.9, 33.7, 26.0, 25.2, 22.5, 22.3, 21.5. MS (ES + ve):
m/ z 280 (M + H+, 60), 186 (10), 102 (25), 95 (100).
N-Tosyl-N-(1-cycloh ep t-1-en yl)m eth yla m in e (16). 1H
NMR: δ 7.74 (2H, dt, J ) 8.2 Hz), 7.30 (2H, dd, J ) 8, 0.4
Hz), 5.65 (1H, t, J ) 6 Hz), 4.48 (1H, t, J ) 6 Hz), 3.42 (2H, d,
J ) 5.6 Hz), 2.43 (3H, s), 2.06-2.00 (4H, m), 1.71-1.65 (2H,
m), 1.44-1.37 (4H, m). 13C NMR: δ 143.3, 139.1, 137.0, 130.3,
129.6, 127.1, 51.4, 32.1, 30.6, 28.1, 26.7, 26.6, 21.5. MS (EI +
(E)- a n d (Z)-N-Tosyl-N-(1-p en t-3-en yl)a m in e (10). 1H
NMR (300 MHz): δ 7.75 (2H, d, J ) 8.1 Hz), 7.31 (2H, dd, J
) 8.1, 0.9 Hz), 5.60 (1H, dtt, J ) 15.3, 6.3, 1.2 Hz), 5.30 (1H,
dtt, J ) 15.3, 6.3, 1.5 Hz), 4.34 (1H, br), 3.53 (2H, tq, J ) 6.3,
1.2 Hz), 2.43 (3H, s), 1.95 (2H, pentq, J ) 7.5, 1.2 Hz), 0.91
(3H, t, J ) 7.5 Hz). 13C NMR (75 MHz): δ 143.3, 137.2, 136.5,
129.6, 127.2, 123.5, 45.3, 25.1, 21.4, 13.1. MS (ES + ve): m/ z
240 (M + H+, 55), 206 (100), 172 (85), 104 (50), 69 (95). HRMS
calcd for C12H17NO2S ) 239.09798; found 239.097496.
ve): m/ z 280 (M + H+, 10), 124 (100). HRMS calcd for C15H21
NO2S ) 279.12927; found 279.12959.
-
N-Tosyl-N-1-(1-cyclop en t -1-en yl)et h yla m in e (18). 1H
NMR: δ 7.73 (2H, d, J ) 8 Hz), 7.28 (2H, d, J ) 8 Hz), 5.41
(1H, s), 4.45 (1H, d, J ) 8 Hz), 4.03 (1H, pent, J ) 7.2 Hz),
2.42 (3H, s), 2.19-2.10 (3H, m), 2.00-1.90 (1H, m), 1.80-1.70
(1H, m), 1.69-1.58 (1H, m), 1.2 (3H, d, J ) 7.2 Hz). 13C NMR
(100 MHz): δ 144.1, 143.0, 138.0, 129.4, 127.2, 126.3, 50.1,